menu
    • menu

    Company profile for Trovagene

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Integrating a Predictive Clinical Biomarker Approach to Develop Oncology Therapeutics that Target Cell Division. We are a clinical-stage oncology therapeutics company, taking a PCMTM approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers. We believe that integrating a predictive clinical biomarker approach into our onvansertib clinical development program...
    Integrating a Predictive Clinical Biomarker Approach to Develop Oncology Therapeutics that Target Cell Division. We are a clinical-stage oncology therapeutics company, taking a PCMTM approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers. We believe that integrating a predictive clinical biomarker approach into our onvansertib clinical development program may enable us to tailor treatment to specific sub-populations of patients who are most likely to respond and have a positive clinical impact.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TrovageneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11055 Flintkote Ave, San Diego, CA 92121
    Telephone
    Telephone
    +1 858-952-7570
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://trovageneoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/trovagene
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/trovagene

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Trovagene Announces Changing of Company Name to Cardiff Oncology
    Trovagene Announces Changing of Company Name to Cardiff Oncology

    06 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/trovagene-announces-changing-of-company-name-to-cardiff-oncology-and-appointment-of-mark-erlander-phd-as-chief-executive-officer-301053690.html

    PRNEWSWIRE
    06 May 2020
    Share Share
    Onvansertib Trial in KRAS-Mutated Colorectal Cancer Demonstrates Tumor
    Onvansertib Trial in KRAS-Mutated Colorectal Cancer Demonstrates Tumor

    28 Apr 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/onvansertib-trial-in-kras-mutated-colorectal-cancer-demonstrates-consistent-tumor-regression-across-kras-mutation-subtypes-and-durable-response-301048164.html

    PR NEWSWIRE
    28 Apr 2020
    Share Share
    Trovagene Announces Acceptance of Phase 1b/2 KRAS-mCRCTrial
    Trovagene Announces Acceptance of Phase 1b/2 KRAS-mCRCTrial

    01 Apr 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/trovagene-announces-acceptance-of-phase-1b2-kras-mutated-metastatic-colorectal-cancer-mcrc-trial-abstract-for-presentation-at-the-2020-asco-annual-meeting-301033146.html

    PR NEWSWIRE
    01 Apr 2020
    Share Share
    Trovagene Presents Ph2 Data the Ability of Onvansertib to Overcome Zytiga®
    Trovagene Presents Ph2 Data the Ability of Onvansertib to Overcome Zytiga®

    13 Feb 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/trovagene-presents-phase-2-data-demonstrating-the-ability-of-onvansertib-to-overcome-zytiga-resistance-and-provide-clinical-benefit-for-mcrpc-patients-301004287.html

    PR NEWSWIRE
    13 Feb 2020
    Share Share
    Trovagene to Present New Clinical Data for Onvansertib
    Trovagene to Present New Clinical Data for Onvansertib

    21 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/trovagene-to-present-new-clinical-data-for-onvansertib-in-metastatic-kras-mutated-colorectal-cancer-at-asco-2020-gastrointestinal-cancers-symposium-300989830.html

    PR NEWSWIRE
    21 Jan 2020
    Share Share
    Trovagene Announces Data from AML Phase 1b/2 Trial of Onvansertib
    Trovagene Announces Data from AML Phase 1b/2 Trial of Onvansertib

    06 Nov 2019

    // BUSINESSWIRE

    https://www.prnewswire.com/news-releases/trovagene-announces-data-from-acute-myeloid-leukemia-aml-phase-1b2-trial-of-onvansertib-chosen-for-oral-presentation-at-ash-2019-annual-meeting-300952602.html

    BUSINESSWIRE
    06 Nov 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search